Added to YB: 2026-01-19
Pitch date: 2026-01-16
BSX [bullish]
Boston Scientific Corporation
Author Info
No bio for this author
Upgrade to Yellowbrick Premium to unlock investor returns. Upgrade to Yellowbrick Premium
Company Info
Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide.
Market Cap
$130.6B
Pitch Price
N/A
Price Target
N/A
Dividend
N/A
EV/EBITDA
27.39
P/E
47.10
EV/Sales
7.32
Sector
Health Care Equipment and Supplies
Category
special_situation
Show full summary:
$BSX Puts Sold On This Acquisition Dip
BSX (options trade): Down 4% on $14.5B Penumbra acquisition, traders selling $80 puts (11.2% OTM) collecting $1.10 premium. High IV from deal + Feb 4 earnings creates opportunity. $80 strike near 52-week low $85.98, analysts maintain Buy ratings w/ $121-$127 targets. Risk: integration concerns.
Read full article (2 min)